4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-068861
Director sold 29,278 shares at $20.39 ($596,949)
- Director acquired 29,278 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ZASLOFF MICHAEL A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-14 | Exercise or conversion : show line 1 in the form | +29,278 | $14.66 | $429,215 | 59,123 | D |
| 2018-11-14 | Sale : show line 2 in the form | −29,278 | $20.39 | $596,949 | 29,845 | D |
| Open-market sales · 29,278 sh · avg $20.39 · $596,949 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-11-14 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −29,278 | 0 | D |
Loading xslF345X03/a4.xml…